
Nicholas Vogelzang, MD, Comprehensive Cancer Center
Advertisement
Articles by Nicholas Vogelzang, MD, Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Repeat Molecular Testing in Advanced Prostate CancerMarch 18th 2020
mCRPC: Advice for Treatment During COVID-19March 18th 2020
CARD Trial In Metastatic CRPCMarch 18th 2020
Sequencing Therapy in Castrate-Resistant Prostate CancerMarch 18th 2020
Counseling Patients With mCRPCMarch 18th 2020
Using Taxanes Frontline in Metastatic Prostate CancerMarch 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
May’s GI Monthly Rewind: A Landmark Approval in CCA, Expanded Access for Daraxonrasib, and More Key Pipeline Updates
5











